Ahmad Awada

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Epidermal Growth Factor Receptor

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Krayem, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, Joseph Kerger, Ahmad Awada, Fabrice Journe, Ghanem E Ghanem
Correction: Krayem et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. Cancers 2020, 12 , 512. Cancers 16 (14) (2024)
Mohammad Krayem, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, Joseph Kerger, Ahmad Awada, Fabrice Journe, Ghanem E Ghanem
Correction: Krayem et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. Cancers 2020, 12 , 512. Cancers 16 (14) (2024)
Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis, Peter Vuylsteke, Richard D Gelber, Nancy Van Damme, Lien van Walle, Arlindo R Ferreira, Matteo Lambertini, Francesca Poggio, Didier Verhoeven, Annelore Barbeaux, Fran Ois P Duhoux, Hans P M W Wildiers, Carmela Caballero, Ahmad Awada, Martine J Piccart, Kevin Punie, Evandro de Azambuja
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium. Breast cancer research and treatment (2024)
Mohammad Krayem, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, Joseph Kerger, Ahmad Awada, Fabrice Journe, Ghanem E Ghanem
Correction: Krayem et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. Cancers 2020, 12 , 512. Cancers 16 (14) (2024)
Ahmad Najem, Mohammad Krayem, Serena Sabbah, Matilde Pesetti, Fabrice Journe, Ahmad Awada, Laurent Désaubry, Ghanem E Ghanem
Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies. Cells 12 (14) (2023)
Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis, Peter Vuylsteke, Richard D Gelber, Nancy Van Damme, Lien van Walle, Arlindo R Ferreira, Matteo Lambertini, Francesca Poggio, Didier Verhoeven, Annelore Barbeaux, Fran Ois P Duhoux, Hans P M W Wildiers, Carmela Caballero, Ahmad Awada, Martine J Piccart, Kevin Punie, Evandro de Azambuja
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium. Breast cancer research and treatment (2023)
Guilherme Nader Marta, Chiara Molinelli, Veronique Debien, Diogo Martins-Branco, Philippe Aftimos, Evandro de Azambuja, Ahmad Awada
Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment. Therapeutic advances in medical oncology 15 (2023)
Diogo Martins-Branco, Guilherme Nader Marta, Ana Tečić Vuger, Veronique Debien, Lieveke Ameye, Mariana Brandão, Kevin Punie, Angela Loizidou, Karen Willard-Gallo, Chloe Spilleboudt, Ahmad Awada, Martine J Piccart, Evandro de Azambuja
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis. Journal of cancer research and clinical oncology (2022)
Julie Marin, Fabrice Journe, Ghanem E Ghanem, Ahmad Awada, Nadège Kindt
Cytokine Landscape in Central Nervous System Metastases. Biomedicines 10 (7) (2022)
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, Michael J Pishvaian, Yung-Jue Bang, Michael S Gordon, Ahmad Awada, D Ross Camidge, F Stephen Hodi, Grant A McArthur, Wilson H Miller, Andres Cervantes, Laura Q M Chow, Alexander M Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang-Chiung Chen, Eric G Stefanich, Tony Pourmohamad, Maria Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L Siu
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Ahmad Najem, Laura Soumoy, Malak Sabbah, Mohammad Krayem, Ahmad Awada, Fabrice Journe, Ghanem E Ghanem
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma. Cells 11 (7) (2022)
Vivek Subbiah, Irene Brana, Alessandra Longhi, Valentina Boni, Jean-Pierre Delord, Ahmad Awada, Pascaline Boudou-Rouquette, John Sarantopoulos, Geoffrey I Shapiro, Anthony D Elias, Ravin Ratan, Cristian Fernandez, Carmen Kahatt, Martin Cullell-Young, Mariano Siguero, Ali Zeaiter, Sant P Chawla
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Kamal S Saini, Kevin Punie, Chris Twelves, Stefanella Bortini, Evandro de Azambuja, Steven Anderson, Carmen Criscitiello, Ahmad Awada, Sherene Loi
Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics. Expert opinion on biological therapy 21 (7) (2021)
Malak Sabbah, Mohammad Krayem, Ahmad Najem, François Sales, Wilson Miller, Sonia Del Rincon, Ahmad Awada, Ghanem E Ghanem, Fabrice Journe
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit. Molecular cancer research : MCR 19 (7) (2021)
Bora Lim, David A Potter, Mohamad A Salkeni, Paula Silverman, Tufia C Haddad, Frederic Forget, Ahmad Awada, Jean-Luc Canon, Michael Danso, Alain Lortholary, Hughes Bourgeois, Elizabeth Tan-Chiu, Sylvie Vincent, Brittany Bahamon, Kevin J Galinsky, Chirag Patel, Rachel Neuwirth, E Jane Leonard, Jennifer R Diamond
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Malak Sabbah, Ahmad Najem, Mohammad Krayem, Ahmad Awada, Fabrice Journe, Ghanem E Ghanem
RTK Inhibitors in Melanoma: From Bench to Bedside. Cancers 13 (7) (2021)
Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lüftner, Sylvie Rottey, Peter A van Dam, Khalil Zaman, Giorgio Mustacchi, Joseph Gligorov, Ahmad Awada, Mario Campone, Hans P M W Wildiers, Alessandra Gennari, Vivianne C G Tjan-Heijnen, Javier Cortes, Mariavittoria Locci, Ida Paris, Lucia Del Mastro, Sabino De Placido, Miguel Martin, Guy Jerusalem, Sergio Venturini, Curigliano Giuseppe, Daniele Generali
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer. Cancers 13 (17) (2021)
James F Spicer, Aurélien Marabelle, Jean-Francois Baurain, Nina Louise Jebsen, Dag Erik Jøssang, Ahmad Awada, Rebecca S Kristeleit, Delphine Loirat, George Lazaridis, Christiane Jungels, Paal Brunsvig, Berit Nicolaisen, Andrew Saunders, Hamina Patel, Jerome Galon, Fabienne Hermitte, Ketil André Camilio, Brynjar Mauseth, Vibeke Sundvold, Baldur Sveinbjørnsson, Øystein Rekdal
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Sara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise Yardley, Arlene Chan, Pierfranco Conte, Véronique Diéras, Nancy U Lin, Melissa Bear, Sonya C Chapman, Zhengyu Yang, Yanyun Chen, Carey K Anders
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Mohammad Krayem, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, Joseph Kerger, Ahmad Awada, Fabrice Journe, Ghanem E Ghanem
Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. Cancers 12 (2) (2020)
Ian Krop, Vandana G Abramson, Marco Colleoni, Tiffany Traina, Frankie Ann Holmes, Laura Garcia-Estevez, Lowell Hart, Ahmad Awada, Claudio Zamagni, Patrick G Morris, Lee Schwartzberg, Stephen Chan, Ayca Gucalp, Laura Biganzoli, Joyce Steinberg, Lorenzo Sica, Maureen Trudeau, Denka Markova, Jamal C Tarazi, Zhou Zhu, Thomas O'Brien, Catherine M Kelly, Eric P Winer, Denise A Yardley
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Georges El Hachem, Andrea Gombos, Ahmad Awada
Abemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer. Expert review of anticancer therapy 21 (1) (2020)
Giacomo Bregni, Tiberio Sticca, Silvia Camera, Tugba Akin Telli, Ligia Craciun, Elena Trevisi, Andrea Pretta, Pashalina Kehagias, Sophia Leduc, Chiara Senti, Amélie Deleporte, Caroline Vandeputte, Everardo Delforge Saad, Joseph Kerger, Thierry Gil, Martine Piccart-Gebhart, Ahmad Awada, Pieter Demetter, Denis Larsimont, Alain Hendlisz, Philippe Aftimos, Francesco Sclafani
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel. Acta oncologica (Stockholm, Sweden) 59 (12) (2020)
Andrea Gombos, Maria Alice B Franzoi, Ahmad Awada
Investigational drugs in early stage clinical trials for the treatment of HER2+ breast cancer. Expert opinion on investigational drugs 28 (7) (2019)
Gaetan Catala, Jeroen Mebis, Guy Jerusalem, Didier Verhoeven, Ahmad Awada, Alain Bols, Luc Somers, Anke Van Den Broeck, Fran Ois P Duhoux, Jean-Pascal Machiels
Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results. Acta clinica Belgica 75 (2) (2019)